At a glance
ClinicalIndex Comparison RecordN/ACompleted· 126 enrolled
Drug / intervention
soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light Produced on Commercial Manufacturing Lines
In Brief
A clinical study evaluating soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore and ACUVUE OASYS 1-Day for Astigmatism for Visual Acuity. Completed, enrolled 126 participants across 10 sites.
Detailed Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartMay 2022
Primary CompletionAug 2022
TodayJul 2026
First PostedApr 25, 2022
Enrollment StartMay 9, 2022
Primary CompletionAug 9, 2022
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.2 years ago
Interventions
soft contact lens in senofilcon A (C3) with HEVL-blocking chromophoredevice
TEST Lens
ACUVUE OASYS 1-Day for Astigmatismdevice
CONTROL Lens